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Available online 2 November 2015Fibroblasts from a Familial Mediterranean Fever (FMF) patient were reprogrammed with episomal vectors by
using the Neon Transfection System for the generation of integration-free induced pluripotent stem cells
(iPSCs). The resulting iPSC line was characterized to determine the expression of pluripotency markers, proper
differentiation into three germ layers, the presence of normal chromosomal structures as well as the lack of ge-
nomic integration. A homozygousmissensemutation in theMEFV gene (p.Met694Val), which lead to typical FMF
phenotype, was shown to be present in the generated iPSC line.
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We reprogrammed ﬁbroblasts obtained from a patient with Fa-
milial Mediterranean Fever (FMF), an autosomal recessively inher-
ited autoinﬂammatory disease caused by mutations in the MEFV
gene (The International FMF Consortium, 1997; French FMF Consor-
tium, 1997). Patient-speciﬁc ﬁbroblasts were transfected with epi-
somal factors expressing, Oct4, Sox2, L-Myc, Klf4, Lin28 and shp53
by using the Neon Transfection System (Invitrogen) based on a. This is an open access article underpreviously published protocol (Fidan et al., 2015; Okita et al.,
2011). The expression of pluripotency genes in the resulting iPSC
line was tested by immunoﬂuorescense staining, using antibodies
against Oct4 and Nanog (Fig. 1).
To demonstrate the capacity of differentiation into three germ
layers, KU_FMF_iPSC_1 cells were injected intramuscularly into SCID
mice (Lensch et al., 2007). The resulting teratomas displayed differenti-
ated cells from three germ layers (Fig. 2).
The three non-integrating episomal vectors were introduced by
using the Neon Transfection System. The presence of non-integrating
episomal vectors was tested by a PCR-based detection method from ge-
nomic DNA of KU_FMF_iPSC_1 (Fig. 3).
The presence of homozygous p.Met694Val mutations in exon 10 of
MEFV gene in the starting ﬁbroblasts and iPSCs was analyzed by geno-
mic DNA sequencing. Results conﬁrmed the presence of p.Met694Val
mutation in the KU_FMF_iPSC_1 line (Fig. 4).2. Materials and methods
2.1. Patient ﬁbroblast culture
A skin punch biopsy from armwas obtained from an FMF patient by
a physician (AG) after the patient have given informed consent under a
protocol approved by the relevant Institutional Review Board. The biop-
sy sample of 3mmskinwaswashedwithDPBS and cut into small pieces
using sterile razor blades. Pieces were cultured in complete DMEM
medium (90% DMEM, 10% FBS). Cell line was established in 2 weeks
by changing the medium every 3 days. Conﬂuent cells were passagedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of an FMF patient induced pluripotent stem cells (iPSC)
KU_FMF_iPSC_1. Immunoﬂuorescence stainings of FMF patient iPSCs with Oct4 and
Nanog. Hoechst was used for nucleus staining.
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DMSO, 50% complete DMEM and 40% FBS.Fig. 2. Teratoma formation of KU_FMF_iPSCs. Injection of iPSC into SCID mice resulted in
teratoma formation. Isolated teratomas were stained with hematoxylin and eosin to visu-
alize three germ layer derivatives. All three germ layer structures were observed.2.2. iPSC generation and expansion
Established FMF patient ﬁbroblastswere transfectedwith 1 μg of the
three plasmids encoding the reprogramming factors (pCXLE-hOCT3/4-
shp53-F, Addgene plasmid 27077; pCXLE-hUL, Addgene plasmid
27080; pCXLE-hSK, Addgene plasmid 27078) using the Neon Transfec-
tion System (Fidan et al., 2015; Okita et al., 2011). Transfected ﬁbro-
blasts were cultured in DMEM medium until day 7. On day 7, patient
ﬁbroblasts were passaged onto mitotically arrested MEFs (Mouse
Embryonic Fibroblasts) in hES medium (20% KOSR, 1% L-glutamine, 1%
non-essential aminoacids, 0.1 mM β-mercaptoethanol, 10 ng/ml bFGF
in DMEM/F12). In order to increase the reprogramming efﬁciency,
3 μM Dot1L inhibitor (EPZ004777, iDot1L) was added during the ﬁrst
2 weeks of reprogramming (Onder et al., 2012). After the successful for-
mation of iPSC colonies, iPSCs were expanded both on MEFs and on
Matrigel in mTeSR1 medium.2.3. Immunoﬂuorescence staining of iPSC
Pluripotent gene expression in KU_FMF_iPSC_1 was conﬁrmed by
Oct4 and Nanog immunoﬂuorescence staining. iPSC colonies were
ﬁxed in 4% paraformaldehyde for 30 min at room temperature. Fixed
cells were blocked with 5% donkey serum and permeabilized with
0.2% Triton-X. Cells were then washed with PBS and stained with Oct4
(Abcam) and Nanog (Abcam) primary antibodies at a 1:200 dilution
and left at +4 °C overnight. Primary antibodies were then washed
with PBS and cellswere treatedwith 488Alexaﬂuor secondary antibody
(Invitrogen) at a 1:500 dilution and incubated at room temperature for
1 h. Cells were mounted with Hoechst 33342 prepared in 50% glycerol/PBS. Images were acquired using a confocal microscope (Nikon Eclipse
90i) (Fig. 1).
2.4. Teratoma formation and characterization
We tested the differentiation ability of iPSCs by teratoma formation.
Undifferentiated iPSCswere expanded onMatrigel (Corning) inmTesR1
medium (Stem Cell Technologies) followed by collection and subse-
quent intramuscular injection into SCID mice. Teratoma formation was
observed 10 weeks after the injection. Resulting teratomas were isolat-
ed, ﬁxed with 10% formalin and stained with hematoxylin and eosin.
Derivatives of three germ layers were observed including cartilage,
glandular structures, melanin pigmented cells and neural rosettes, all
of which demonstrate the pluripotency of the injected iPSCs (Fig. 2).
Fig. 3. Integration assay. PCR-basedmethod demonstrated that episomal vectors were not
integrated into the genomic DNA of KU_FMF_iPSCs. pCXLE-SK plasmid containing EBNA
sequence was used as positive control.
Fig. 5. Karyotype analysis. Patient iPSC has normal karyotype, 44+XY.
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Episomal vectors are considered non-integrating, however, a low
probability of integration still exists. To test the integration of episomal
vectors, genomic DNA was isolated from KU_FMF_iPSCs using a com-
mercial genomicDNA isolation kit (Qiagen). An EBNA sequence, encoded
by all three vectors, was used to analyze the genomic integration of
episomal vectors by PCR. Results demonstrate that iPSCs were
established as integration-free cell line (Fig. 3). The following primers
were used for PCR: EBNA-Fwd: AGGGCCAAGACATAGAGATG, EBNA-
Rev: GCCAATGCAACTTGGACGTT, GAPDH-Fwd: ATCACCATCTTCCAGG
AGCGA, GAPDH-Rev: TTCTCCATGGTGGTGAAGACG.2.6. Mutation analysis of iPSCs
The FMF patient whose ﬁbroblasts were reprogrammed carried a
homozygous p.Met694Val mutation in the MEFV gene. Genomic DNA
from KU_FMF_iPSCs were isolated, and exon 10 ofMEFV gene was am-
pliﬁed by PCR using the following primers: Exon10-Fwd: TTCCAGAAGA
ACTACCCTGT, Exon10-Rev: TGCATTTCCCATAGCAGCTA. Sanger se-
quencing was performed which indicated the presence of homozygous
single nucleotide mutation that leads to p.Met694Val in patient's iPSCs
(Fig. 4).Fig. 4.Mutation detection in patient iPSCs. Mutation in theMEFV gene leading toM694V is
indicated in iPSCs (blue arrows point the mutated nucleotide in patient iPSCs).2.7. Karyotyping
Karyotyping of KU_FMF_iPSCswas carried out at a clinical diagnostic
center (Nesiller Genetics, Turkey). G-banding was utilized to karyotype
the FMF patient's iPSC line. Cells were arrested in metaphase and ana-
lyzed. All ten metaphase cells counted had 44+XY chromosomes as
shown in Fig. 5.
3. Veriﬁcation and authentication
Identity and purity of KU_FMF_iPSC_1 was conﬁrmed by immuno-
ﬂuorescence for the expression of stem cell markers Oct4 and Nanog,
karyotyping, and in vivo teratoma formation. In addition, geno-
mic DNA from KU_FMF_iPSC_1 carried no detectable integration of the
reprogramming plasmids. The presence of the disease-relevant muta-
tion in theMEFV gene was conﬁrmed by DNA sequencing.
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